Costotransverse Foramen Block With Erector Spinae Plane Block in Modified Radical Mastectomy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-65
SponsorNational Cancer Institute, Egypt
About this trial
This study aims to compare the costotransverse foramen block with erector spinae plane block in modified radical mastectomy.
Eligibility criteria
Qualifiers
Adult females > 18 years and ≤ 65 years old.
American Society of Anesthesiologists (ASA) physical status П-III.
Body mass index (BMI) 18-35 kg/m2.
Scheduled for modified radical mastectomy.
Disqualifiers
Known allergy or hypersensitivity to local anesthetic agents.
Active infection at the injection site (e.g., cellulitis, abscess).
Coagulopathy or ongoing anticoagulant/antiplatelet therapy [International Normalized Ratio (INR) > 1.5 or platelet count < 100,000/µL].
Severe respiratory, cardiac, hepatic, or renal disease.
Trial design
Treatments tested in this trial
- Costotransverse foramen block
- Erector spinae plane block
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov